When enteral nutrition is excluded from animals maintained solely with total parenteral nutrition (TPN). atrophy of the intestinal mucosa is observed. Short-chain fatty acids (SCF As) are produced in the colon by the fermentation of dietary carbohydrates and fiber polysaccharides and have been shown to stimulate mucosal-cell mitotic activity in the intestine. This study compared the effects'of an intravenous and an intracecal infusion ofSCFAs on the small-bowel mucosa. Rats received standard TPN. TPN with SCFAs (sodium acetate. propionate. and butyrate). TPN with an intracecal infusion of SCFAs. or rat food. After 7 d jejunal and ileal mucosal weights. DNA. RNA. and protein were determined. Standard TPN produced significant atrophy of the jejunal and ileal mu-CC:'sa. Both the intracecal and intravenous infusion of SCFAs significantly reduced the mucosal atrophy associated with TpN. The intravenous and intracolonic infusion of SCFAs were equally effective in inhibiting small-bowel mucosal atrophy.
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Twenty-five adult male Sprague-Dawley rats (275-325 g) were housed in individual metabolic cages and fed a fiber-free liquid rat diet (Bioserv, Freehold. NJ) ad libitum for 3 d. This diet was given to minimize the effect of residual dietar}' fiber fermentation, and thus SCF A production. during the course of the experiment. On the fourth day all rats were anesthetized and underwent superior vena cava cannulation with swivel placement. In addition, five animals underwent insertion of a cecal catheter attached to a tw0-<:hannel swivel to permit simultaneous intravenous and intracecal infusions. Sham laparotomies with cecal manipulation were performed on the 20 animals that did not rcceive cecal catheters.
Postoperatively the five animals with cecal catheters received standard TPN with an intracecal infusion of SCFAs (Cec-SCF A. n = 5). The remaining animals were randomly assigned to receive either standard TPN (Control, n = 5), TPN supplemented with intravenous SCFAs (IV-SCFA. n = 8). or 0.45% saline intravenously with standard rat food ad libitum (Food. n = 7). The TPN and intracecal solutions were prepared daily with the compositions outlined in Table I . SCFAs (acetate. propionate. and n-butyrate) were added to the IV-SCFA TPN as the sodium salts (Sigma Chemical Co, St Louis) according to the proportjons of Sakata and Englehardt (13) . Sixty-two milliliters of the diets were infused daily to provide -1.5 g N .
kg-'.d-J and 206 nonprotein kcal.kg-l.d-1 (Table I ). All ani. mals were offered water ad libitum during the feeding period.
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Statistical analysis
All data are presented as the mean :t SEM. Paired t tests were used to evaluate the changes in body weight. Analysis of variance (ANOV A) was performed on each variable. When the ANOV A indicated a significant effect, t tests were used to make post hoc comparisons between dietary groups; p < 0.05 wa! considered significant (23) .
Results
Nutritiona/ variab/es There were no significant differences in total dietary nitrogeJ intake, urinary and fecal nitrogen excretion, and nitrogen bal ance among the three groups that received TPN ( Table 2 ). Sim ilarly, there were no significant differences among the fou groups for absolute change in body weight or for percer change in body weight (Table 3 ).
Urine and feces were collected from the three groups receiving TPN during diet infusion for total nitrogen determinations ( 16) . Because of the inherent difficulties and inaccuracies associated with monitoring the actual ingestion of food by rats, we elected not to include the Food group in the nutrient balance studies.
The cecal infusion consisted of the sodium salts of acetate, propionate, and n-butyrate (Sigma Chemical Co) ( Table I) . These concentrations were chosen to approximate the profile ofSCFAs in normal rat colon ( 13) . The pH of the solution was adjusted to 7.0 with concentrated HCI. Thirty milliliters per day were infused intracecally so that the Cec-SCF A and IV-SCFA groups received similar amounts ofSCFAs.
On the seventh postoperative day animals were anesthetized and weighed and the intestine from the ligament of Trietz to the cecum was rapidly excised and rinsed in ice-cold saline. While the intestine was suspended with a 10-g weight, standardized 10-cm segments of jejunum (just distal to the ligament ofTrietz) and ileum (just proximal to the ileocecal junction) were obtained. The mucosa from the intestinal segments was harvested as previously described ( 17) and was weighed, homogenized in water (20-40 mg/mL), and frozen at -25 °C until assayed for DNA ( 18, 19) , RNA (20), and protein (21 ) .
The entire liver from each animal was removed and weighed. Liver water content was determined gravimetrically by vacuum dessication at 90 °C. Liver fat content was determined by
Mucosal variables
In general there were su~tantial decreases in mucosal weigl and in DNA, RNA, and protein contents in the TPN groul compared with the Food group (Table 4) . In both the jejunuJ and ileum, the Control group had significantly lower mucos ever, in contrast to the other mucosal variables, the jejunal DNA for the IV -SCF A, Cec-SCF A, and Food groups did not differ significantly.
Changes in mucosal cell size are reflected by the ratio ofRNA to DNA (24) , particularly in early cell growth. The ratio of RNA to DNA did not differ significantly in the jejunum and ileum among the groups (Table 5) .
weights than did the IV -SCF A, Cec-SCF A, and Food groups (Fig I ) . The jejunal and ileal mucosal weights of the IV -SCF A and Cec-SCF A groups were significantly greater than those of the Control group and significantly less than those of the Food group but were not significantly different from each other. The same statistical relationship among groups was found for jejunal and ileal mucosal RNA (Fig 2) , ileal mucosal protein content (FIg 3) , and ileal mucosal DNA content (Fig 4) .
Jejunal mucosal protein contents (Fig 3) of the Control and C«-SCFA groups were significantly lower than the protein content of the Food group whereas the protein contents of the IV-SCFA and Food groups did not significantly differ. Jejunal DNA content (Fig 4) of the Control group was significantly lower than the mucosal DNA of the other three groups. HowLiver There were no significant differences in total liver weight, percent water content, percent fat content, and nitrogen content among the groups (Table 6) .
Discussion
These data demonstrate that compared with rat-food-fed rats, rats given standard TPN for 7 d showed significant muco- 
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ET AL sal atrophy of the jejunum and ileum. This is indicated by sub-TABLE 6 . stantial decreases in mucosal weight and in DNA, RNA, and Liver composition* protein contents (Table 4 ). This finding is consistent with previous observations that jejunal and ileal mucosal atrophy occurs when animals are maintained solely with TPN ( 1-4). More importantly, the present study demonstrates that the provision of SCFAs, either intravenously or intracecally, during TPN resulted in significantly less mucosal atrophy in the jejunum and ileum as indicated by smaller losses of mucosal weight and DNA, RNA, and protein contents ( Table 4 ). The effects of the SCF As on the small-bowel mucosa appear to be somewhat more pronounced in the jejunum than in the ileum. There is a tendency for the jejunal mucosa of the IV-SCFA and Cec-SCF A groups to experience a smaller decrease in the mucosal variables than the ileal mucosa. Gastrointestinal mucosal growth is influenced by many factors such as the presence and type of luminal nutrients (25-28), pancreatic and biliary secretions (29-31 ), circulating enterohormon~s (32) , and neurovascular reflexes (28). The atrophy of the intestinal mucosa that results from parenteral nutrition is thought to be mediated by one or more of these factors.
The mechanisms by which SCF As may influence smallbowel mucosal proliferation is not clearly understood. Because SCF As are normally produced in the colon by the bacterial fermentation of dietary carbohydrates and fiber polysaccharides (5, 6) , the initial studies that demonstrated the effects ofSCF As on small-bowel mucosal proliferation were performed in a model where the SCF As were directly infused into the colon ( 12, 13 ) . These studies suggested that the intracolonic presence of SCF As was necessary to exert their effects on the small bowel. However, the present study demonstrates that the intravenous and intracolonic infusion of SCF As was equally effective in inhibiting small-bowel mucosal atrophy, indicating that the site of administration does not significantly influence the effects ofSCFAs on the small-bowel mucosa.
SCF As have several systemic effects that may influence intestinal mucosal proliferation. SCFAs, particularly acetate, increase intestinal blood flow (33), which may enhance mucosal proliferation (34). The autonomic nervous system has been shown to mediate some of the effects ofSCFAs on the colonic mucosa ( 13) . Pancreatic secretions are known to stimulate mucosal proliferation (29) (30) (31) , and the intravenous infusion of SCF A, especially butyrate, was shown to increase pancreatic secretion (35). Circulating enterohormones playa significant role in intestinal mucosal proliferation. Although SCFAs stimulate the release of insulin (36), to our knowledge there have been no studies that have examined the effect ofSCFAs on the secretion of humoral factors or gut hormones that mediate intestinal mucosal proliferation.
SCF As, which are normally produced in the colon, are readily absorbed and metabolized by the colonic mucosa. Apart yom the colonic mucosa, the liver is the main site of SCFA metabolism (37). Hepatic metabolism and clearance of SCF As are substantial because portal concentrations of SCF As are 150% greater than the concentrations of SCF As simultaneously determined in the hepatic vein and 375% greater than systemic SCFA concentrations (38). This suggests that the effects ofSCFAs on the small-bowel mucosa are indirect, perhaps produced by other mediators. ProductsofSCFA metabolism may provide the mediators of SCFA mucosal trophism (39). The hepatic metabolism of both intraportally infused and intravenously administered SCF As results in the production of the ketone bodies acetoacetate and fJ-hydroxybutyrate as well as the amino acids glutamine and glutamate ( 40, 41 ). Ketone bodies and glutamine are major respiratory fuels of the small intestine (42). Glutamine, fJ-hydroxybutyrate, and acetoacetate have been shown to be trophic to the small bowel and colon (39,43). Therefore, it would appear that via common hepatic metabolism to the preferred intestinal fuel sources, both the portally delivered SCFAs (cecal infusion) and the intravenously infused SCFAs would have similar effects on the intestinal mucosa, as found in the present study.
The caloric contribution of the SCFAs should be considered as possibly influencing the effects on the small-bowel mucosa. Assuming the caloric densit~ of the SCFAs to be 3.4 kcal/g for acetate, 5.0 kcal/g for propionate, and 6.0 kcal/g for butyrate (44) , the animals supplemented with intravenous or intracecal SCF As would receive only 2% more nonprotein calories than the Control TPN group. It is unlikely that this minimal increase in caloric density for the SCF A groups would influence the results because neither change in body weight nor nitrogen balance differed significantly among groups.
In summary, standard TPN given to normal rats for 7 d resulted in significant atrophy of the mucosa of the jejunum and ileum. Both the intracecal and intravenous infusion of SCF As produced similar effects on the small-bowel mucosa, significantly reducing the small-bowel mucosal atrophy associated with TPN. Further studies are needed to determine the mechanisms whereby SCFAs stimulate the small-bowel epithelium. n
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